home / stock / smfrw / smfrw quote
Last: | $0.024 |
---|---|
Change Percent: | -7.91% |
Open: | $0.025899 |
Close: | $0.024 |
High: | $0.026 |
Low: | $0.0181 |
Volume: | 19,048 |
Last Trade Date Time: | 01/09/2023 01:57:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.024 | $0.025899 | $0.024 | $0.026 | $0.0181 | 19,048 | 01-09-2023 |
$0.024 | $0.0265 | $0.024 | $0.0265 | $0.017 | 6,121 | 01-06-2023 |
$0.0239 | $0.015949 | $0.0239 | $0.024 | $0.015949 | 21,882 | 01-05-2023 |
$0.0185 | $0.0116 | $0.0185 | $0.0188 | $0.0116 | 2,875 | 01-04-2023 |
$0.019 | $0 | $0.019 | $0 | $0 | 163 | 01-03-2023 |
$0.019 | $0.017 | $0.019 | $0.02 | $0.0112 | 128,026 | 01-02-2023 |
$0.019 | $0.017 | $0.019 | $0.02 | $0.0112 | 128,026 | 12-30-2022 |
$0.017 | $0.0138 | $0.017 | $0.0175 | $0.0136 | 136,842 | 12-29-2022 |
$0.017 | $0.011 | $0.017 | $0.017 | $0.011 | 162,367 | 12-28-2022 |
$0.0113 | $0.01 | $0.0113 | $0.0155 | $0.01 | 100,670 | 12-27-2022 |
$0.014 | $0.0152 | $0.014 | $0.017 | $0.013 | 83,555 | 12-26-2022 |
$0.014 | $0.0152 | $0.014 | $0.017 | $0.013 | 83,555 | 12-23-2022 |
$0.0152 | $0.0145 | $0.0152 | $0.017 | $0.013 | 67,885 | 12-22-2022 |
$0.016599 | $0.014 | $0.016599 | $0.0171 | $0.014 | 65,750 | 12-21-2022 |
$0.0178 | $0.013101 | $0.0178 | $0.018 | $0.013 | 35,700 | 12-20-2022 |
$0.0193 | $0.0146 | $0.0193 | $0.0198 | $0.0133 | 62,165 | 12-19-2022 |
$0.02 | $0.025 | $0.02 | $0.025 | $0.014 | 678,288 | 12-16-2022 |
$0.0247 | $0.0133 | $0.0247 | $0.025 | $0.0133 | 49,671 | 12-15-2022 |
$0.0248 | $0.02 | $0.0248 | $0.027 | $0.0131 | 26,540 | 12-14-2022 |
$0.0199 | $0.0279 | $0.0199 | $0.0279 | $0.013 | 121,862 | 12-13-2022 |
News, Short Squeeze, Breakout and More Instantly...
Sema4 Holdings Corp. Warrant Company Name:
SMFRW Stock Symbol:
NASDAQ Market:
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis ® platforms Company’s common stock will trade on the Nasdaq under new ticker “WGS” effective January 10, 2023 STAMFO...
STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland , President and Chief Executive Officer, will del...
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings support the addition of mitochondrial DNA (mtDNA) testing to rapid exome sequencing, showing it ca...